1. From Ontogeny, Inc, Cambridge, MA; the Division of Hematology-Oncology, Children’s Hospital, Dana-Farber Cancer Institute and the Department of Pediatrics, Harvard Medical School, Boston, MA; the Department of Medicine, Committee on Immunology, University of Chicago, Chicago, IL; the Division of Hematology, Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA; and the Howard Hughes Medical Institute, Boston, MA.